1288 Organometallics, Vol. 19, No. 7, 2000
Stark et al.
lithium (3.3 equiv) was added and the mixture stirred for 20
min at this temperature. The cooling bath was then removed
and the solution warmed to room temperature for 30 min
before replacing the cooling bath. This solution was transferred
via a cannula into a flask containing a solution of the relevant
1,3-bis(2′-oxazolinyl)benzene (1 equiv) and N,N,N′,N′-tetra-
methylethylenediamine (TMEDA) (3 equiv) in THF (20 mL/g
of oxazoline) under a nitrogen atmosphere at -78 °C. After
the addition was complete, the cooling bath was removed and
the resulting deep red solution was stirred at room tempera-
ture for 5-7 h. This was then added by cannula in small
fractions to a stirred suspension of dibromo(1,5-cycloocta-
diene)palladium(II) (1.5 equiv) in THF (20 mL/g) at 0 °C. After
the addition was completed, the ice bath was removed and the
reaction mixture stirred overnight at room temperature. The
resulting black solution was filtered through Celite 520 and
purified by column chromatography.
(S,S)-[2,6-Bis(4′-ter t-bu tyl-2′-oxa zolin yl)p h en yl]p a lla -
d iu m (II) Br om id e (6d ). LDA (9.1 mmol), 5d (1.00 g, 3.0
mmol), TMEDA (1.06 g, 9.1 mmol) in THF (20 mL), and [PdBr2-
(1,5-COD)] (1.71 g, 4.6 mmol) in THF (30 mL) followed by
column chromatography (CH2Cl2-light petroleum (4:1)) gave
6d as an orange solid (0.38 g, 24%). Mp: 258-260 °C. Anal.
Found: C, 46.53; H, 5.77; N, 5.13. Calcd for C20H27BrN2O2Pd:
C, 46.76; H, 5.30; N, 5.45. [R]D20 ) +600 (c 0.1, EtOH). IR (νmax
;
Nujol): 1610 (CdN) cm-1. H NMR (δ; CDCl3): 1.10 (18 H, s,
-C(CH3)3), 4.05 (2 H, dd, J ) 8.4, 2.1 Hz, -OCHH-), 4.50 (2
H, t, J ) 8.8, -CHN-), 4.76 (2 H, dd, J ) 9.1, 2.2, -OCHH-),
7.12 (1 H, t, J ) 7.8, 4-H), 7.24 (2 H, d, J ) 7.5, 3- & 5-H).
13C{1H} NMR (δ; CDCl3): 27.0 (-CH3), 35.8 (-C(CH3)3), 70.8
(-CHN-), 74.1 (-OCH2-), 124.5 (Ph, 4-C), 127.3 (Ph, 3- &
5-C), 129.7 (Ph, 2- & 6-C), 167.0 (Ph, 1-C), 175.1 (CdN). MS
(m/z; EI): 514 (M+, 2%), 438 (8), 437 (43), 435 (86), 433 (93),
432 (73), 431 (34) [all M - Br], 375 (8), 271 (32), 249 (7), 213
(8), 185 (6), 144 (13), 130 (7), 116 (15), 103 (7), 89 (12), 80 (8),
57 (100).
1
[2,6-Bis(4′,4′-d im eth yl-2′-oxa zolin yl)p h en yl]p a lla d iu m -
(II) Br om id e (6a ). LDA (3.3 mmol), 5a (0.300 g, 1.10 mmol),
TMEDA (0.385 g, 3.31 mmol) in THF (8 mL), and [PdBr2(1,5-
COD)] (0.45 g, 1.2 mmol) in THF (10 mL) followed by column
chromatography [CH2Cl2-EtOAc (9:1)] gave 6a as a pale yellow
solid (0.176 g, 35%). Mp: 295-297 °C. Anal. Found: C, 42.28;
H, 4.28; N, 6.27. Calcd for C16H19BrN2O2Pd: C, 41.99; H, 4.18;
(S,S)-[2,6-Bis(4′-cycloh exylm eth yl-2′-oxazolin yl)ph en yl]-
p a lla d iu m (II) Br om id e (6e). LDA (7.4 mmol), 5e (1.00 g,
2.5 mmol), TMEDA (0.85 g, 7.3 mmol) in THF (20 mL), and
[PdBr2(1,5-COD)] (1.50 g, 4.0 mmol) in THF (30 mL) followed
by column chromatography (CH2Cl2-light petroleum (4:1))
gave 6e as a pale yellow solid (0.60 g, 41%). Mp: 264-266 °C.
N, 6.12. IR (νmax; Nujol): 1618 (CdN) cm-1 1H NMR (δ;
.
CDCl3): 1.68 (12 H, s, -CH3), 4.46 (4 H, s, -OCH2-), 7.17 (1
H, t, J ) 7.8 Hz, 4-H), 7.30 (2 H, d, J ) 7.8, 3- & 5-H). 13C{1H}
NMR (δ; CDCl3): 28.1 (-CH3), 66.2 (-C(CH3)2-), 82.8
(-OCH2-), 124.0 (Ph, 4-C), 126.8 (Ph, 3- & 5-C), 130.0 (Ph, 2-
& 6-C), 167.5 (Ph, 1-C), 172.6 (CdN). MS (m/z; EI): 462 (2%),
460 (7), 458 (10), 457 (5), 456 (7), 455 (4), 454 (2) [all M+], 381
(34), 379 (75), 377 (88), 376 (67), 375 (32) [all M - Br], 41 (100).
(S,S)-[2,6-Bis(4′-isop r op yl-2′-oxa zolin yl)p h en yl]p a lla -
d iu m (II) Br om id e (6b). LDA (5 mmol), 5b (0.500 g, 1.66
mmol), TMEDA (0.590 g, 5.08 mmol) in THF (10 mL), and
[PdBr2(1,5-COD)] (0.94 g, 2.5 mmol) in THF (20 mL) followed
by column chromatography (CH2Cl2) and further purification
by precipitation from CHCl3/hexane gave 6a as a pale yellow
solid (0.331 g, 41%). Mp: >290 °C. Anal. Found: C, 44.15; H,
4.77; N, 5.50. Calcd for C18H23BrN2O2Pd: C, 44.51; H, 4.78;
Anal. Found: C, 52.71; H, 5.83; N, 4.63. Calcd for C26H35-
20
BrN2O2Pd: C, 52.58; H, 5.94; N, 4.72. [R]D ) +68 (c 0.1,
EtOH). IR (νmax; Nujol): 1612 (CdN) cm-1 1H NMR (δ;
.
CDCl3): 1.00-1.73 (24 H, m, -CHHCy), 2.46 (2 H, brt, J )
8.3 Hz, -CHHCy), 4.29-4.35 (2 H, m, -CHN-), 4.46 (2 H,
dd, J ) 8.5, 6.0, -OCHH-), 4.72 (2 H, t, J ) 8.9, -OCHH-),
7.08 (1 H, t, J ) 7.8, 4-H), 7.22 (2 H, d, J ) 7.6, 3- & 5-H).
13C{1H} NMR (δ; CDCl3): 26.6 (-CH2-), 32.5 (-CH2-), 34.6
(-CH2-), 35.3 (-CH2CH-), 43.0 (-CH2-), 61.6 (-CHN-),
76.9 (-OCH2-), 124.3 (Ph, 4-C), 127.0 (Ph, 3- & 5-C), 130.0
(Ph, 2- & 6-C), 168.7 (Ph, 1-C), 174.2 (CdN). MS (m/z; EI):
519 (5%), 518 (18), 516 (37), 514 (40), 513 (29), 512 (13) [all M
- Br], 408 (5), 81 (14), 79 (18), 55 (100).
Rea ction of (R,R)-1,3-Bis(4′-p h en yl-2′-oxa zolin yl)ben -
zen e (5f) w it h LDA/TME DA. (R,R)-1,3-Bis(4′-phenyl-2′-
oxazolinyl)benzene (5f; 0.50 g, 1.4 mmol) was lithiated as
described for the formation of 6a -e (LDA, 4.1 mmol; TMEDA,
0.47 g, 4.0 mmol; THF, 20 mL) except that after stirring at
room temperature for 5 h the reaction was quenched by the
addition of MeI (1.93 g, 13.6 mmol). The resultant precipitate
was removed by filtration and the filtrate diluted with EtOAc
(25 mL), washed with water (2 × 20 mL), dried (MgSO4), and
filtered and the solvent removed in vacuo. Recrystallization
from EtOAc/hexane gave enamide 7 (0.522 g, 97%) as a brown
solid. Mp: 117-121 °C. IR (νmax; Nujol): 1650 (CdO), 1635
20
N, 5.77. [R]D ) +128 (c 0.1, EtOH). IR (νmax; Nujol): 1620
(CdN) cm-1 1H NMR (δ; CDCl3): 0.81 (6 H, d, J ) 6.9 Hz,
.
-CH3), 0.94 (6 H, d, J ) 6.9, -CH3), 2.85-2.94 (2 H, m,
-CH(CH3)2), 4.34-4.39 (2 H, m, -CHN-), 4.60-4.69 (4 H,
m, -OCH2-), 7.18 (1 H, t, J ) 7.6, 4-H), 7.32 (2 H, d, J ) 7.4,
3- & 5-H). 13C{1H} NMR (δ; CDCl3): 14.4 (-CH3), 19.3 (-CH3),
29.6 (-C(CH3)2), 67.5 (-CHN-), 71.5 (-OCH2-), 124.5 (Ph,
4-C), 127.4 (Ph, 3- & 5-C), 129.7 (Ph, 2- & 6-C), 168.4 (Ph, 1-C),
174.4 (CdN). MS (m/z; EI): 490 (1%), 488 (5), 486 (8), 485 (5),
483 (2), 482 (1) [all M+], 411 (5), 409 (21), 407 (14), 405 (47),
403 (53), 402 (56) [all M - Br], 361 (7), 257 (12), 43 (100).
(S,S)-[2,6-Bis(4′-isob u t yl-2′-oxa zolin yl)p h en yl]p a lla -
d iu m (II) Br om id e (6c). LDA (4.6 mmol), 5c (0.50 g, 1.5
mmol), TMEDA (0.53 g, 4.6 mmol) in THF (10 mL), and [PdBr2-
(1,5-COD)] (0.85 g, 2.3 mmol) in THF (15 mL) followed by
column chromatography (CH2Cl2) gave 6c as a pale yellow solid
(0.16 g, 21%). Mp: >270 °C. Anal. Found: C, 46.75; H, 5.33;
N, 5.21. Calcd for C20H27BrN2O2Pd: C, 46.76; H, 5.30; N, 5.45.
1
(CdC) cm-1. H NMR (δ; CDCl3): 3.13 (6 H, s, -CH3), 4.69 (2
H, s, -CdCHH), 5.23 (2 H, s, -CdCHH), 6.93 (2 H, d, J ) 7.5
Hz, 4- & 6-H), 7.19-7.30 (11 H, m, Ph and 5-H), 7.62 (1 H, s,
2-H). 13C{1H} NMR (δ; CDCl3): 37.1 (-CH3), 112.9 (-CdCH2),
126.4 (4- & 6-C), 127.6 (-Ph), 127.8 (-Ph), 129.2 (-Ph), 129.4
(-Ph), 129.4 (-Ph), 136.2 (-Ph), 136.5 (1- & 3-C), 149.4
(-CdCH2), 171.2 (CdO). MS (m/z; EI): 396 (M+, 73%), 381 (12),
366 (80), 292 (45), 277 (10), 263 (68), 249 (32), 235 (91), 220
(20), 207 (40), 198 (44), 178 (100), 172 (58), 165 (42), 145 (70),
134 (64), 118 (88), 103 (90), 90 (69), 75 (68), 65 (81) High-
resolution MS (m/z; EI): found for M+, 396.1837; calcd for
[R]D20 ) +146 (c 0.1, EtOH). IR (νmax; Nujol): 1616 (CdN) cm-1
.
1H NMR (δ; CDCl3): 0.98 (6 H, d, J ) 6.6 Hz, -CH3), 1.01 (6
H, d, J ) 6.6, -CH3), 1.36-1.44 (2 H, m, -CH(CH3)2), 1.65-
1.70 (2 H, m, -CHH-), 2.44-2.51 (2 H, m, -CHH-), 4.33-
4.40 (2 H, m, -CHN-), 4.54 (2 H, dd, J ) 8.6, 6.0, -OCHH-),
4.80 (2 H, t, J ) 9.0, -OCHH-), 7.16 (1 H, t, J ) 7.4, 4-H),
7.30 (2 H, d, J ) 7.4, 3- & 5-H). 13C{1H} NMR (δ; CDCl3): 21.7
(-CH3), 23.7 (-CH3), 25.5 (-CH(CH3)2), 43.8 (-CH2-), 61.6
(-CHN-), 76.4 (-OCH2-), 123.9 (Ph, 4-C), 126.7 (Ph, 3- &
5-C), 129.6 (Ph, 2- & 6-C), 168.3 (Ph, 1-C), 173.8 (CdN). MS
(m/z; EI): 514 (M+, 1%), 437 (42), 435 (83), 433 (100), 432 (77),
431 (37) [all M - Br], 376 (5), 327 (2), 271 (10), 57 (36), 55
(39).
C
26H24N2O2, 396.1838.
Rea ction of (S,S)-1,3-Bis(4′-ben zyl-2′-oxa zolin yl)ben -
zen e (5g) w ith LDA/TMEDA. (S,S)-1,3-Bis(4′-benzyl-2′-ox-
azolinyl)benzene (5g; 0.54 g, 1.4 mmol) was lithiated and
quenched as described for the formation of 7 (LDA, 4.08 mmol;
TMEDA, 0.47 g, 4.0 mmol; THF, 20 mL; MeI, 1.93 g, 13.6
mmol). Identical workup and removal of the solvent in vacuo
gave cinnamyl alcohol 8 (0.147 g, 40%) as a yellow oil which
solidified on cooling, Mp: 35-36 °C (lit. mp 34 °C). IR (νmax
;
1
Nujol): 3334 (O-H) cm-1. H NMR (δ; CDCl3): 4.17 (2 H, d,